DLC1 and cancer: In addition, the lack of increased RHOA activity in DLC1 KD melanoma cells could be due to predominant nuclear localization of endogenous DLC1, which was shown to be less efficient in mediating RHOA inhibition in other cancer cell types compared with cytoplasmic DLC1 [25].